# Sri Krishna Pharmaceuticals, Ltd. - Unit III – FDA Inspection, Jul 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-iii/bfd65ca0-6288-4752-be58-bf323fa42b5c
Source feed: FDA_Inspections

> FDA inspection 1216334 of Sri Krishna Pharmaceuticals, Ltd. - Unit III, July 31, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216334
- Company Name: Sri Krishna Pharmaceuticals, Ltd. - Unit III
- Inspection Date: 2023-07-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 954833 - 2015-10-23](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-iii/2853273d-d209-4c2c-bc69-d55e0b02bd2c)
- FDA Inspection 757343 - 2011-11-25

## Related Officers

- [Investigator](https://www.keypedia.com/people/sandra-a-boyd/c469103a-0917-407a-b9d1-98273358dfeb)
- [Vaishali J. Patel](https://www.keypedia.com/people/vaishali-j-patel/3d515b84-e0fd-4f96-914c-f7f09e2de307)

Company: https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-ltd-unit-iii/a5f2eafb-ac51-432f-af12-b1e114c64964

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c